Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-04-16, Stock:PFE, The news for the past five days is as follows:
2020-04-08: NEWS1: U.S. FDA Approves BRAFTOVI® (Encorafenib) in Combination with Cetuximab for the Treatment of BRAFV600E-Mutant Metastatic Colorectal Cancer (CRC) After Prior Therapy.NEWS2: Pfizer Stock Rises 3%.
2020-04-09: NEWS1: The Dow Gained 286 Points Because the Fed Stepped Up Again.NEWS2: N.J. Sees Peak in Three Days; Johnson Out of ICU: Virus Update.NEWS3: Pfizer, BioNTech, Arcturus Share Timelines For Human Testing As COVID-19 Vaccine Development Intensifies.NEWS4: These 20 companies are working on coronavirus treatments or vaccines — here’s where things stand.NEWS5: Bill de Blasio: 3 Things That Need to Happen for New York City to Reopen.NEWS6: Pfizer Stock Rises 3%.NEWS7: Pfizer's Braftovi Combo Gets FDA Nod for Colorectal Cancer.NEWS8: Covid Report: Pfizer Selects Lead Coronavirus Drug; Gilead Updates Tests.NEWS9: Pfizer announces 'important advances' in fight against coronavirus.NEWS10: Pfizer Wants to Start Human Trials for Coronavirus Therapy This Summer.NEWS11: Pfizer discloses $185 million upfront payment to BioNTech for COVID-19 vaccine program.NEWS12: Pfizer Aims to Test Early Coronavirus Treatment by Summer.NEWS13: The Daily Biotech Pulse: FDA Nod For Pfizer, Vanda Forges Partnership For COVID-19 Drug Research, Neuronetics Pre-Announces Revenue Shortfall.NEWS14: Pfizer and BioNTech Announce Further Details on Collaboration to Accelerate Global COVID-19 Vaccine Development.NEWS15: Pfizer Advances Battle Against COVID-19 on Multiple Fronts.NEWS16: Pfizer says early studies of potential coronavirus treatment show promise.NEWS17: Pfizer says early studies of potential coronavirus treatment show promise.NEWS18: Merck and Pfizer Receive US FDA Breakthrough Therapy Designation and Submit Application for BAVENCIO(R) for First-Line Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma.NEWS19: EMD Serono and Pfizer Receive US FDA Breakthrough Therapy Designation and Submit Application for BAVENCIO® for First-Line Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma.
2020-04-13: NEWS1: Top Analyst Reports for Alibaba, Pfizer & S&P Global.NEWS2: Pfizer (PFE) Progressing Well With its Coronavirus Program.NEWS3: These 21 companies are working on coronavirus treatments or vaccines — here’s where things stand.NEWS4: Pfizer Joins Virus Vaccine Hunt in Partnership With German Drugmaker.
2020-04-14: NEWS1: The Zacks Analyst Blog Highlights: Alibaba, Pfizer, S&P Global, Novo Nordisk and Duke Energy.NEWS2: Will Stem Cell Therapies Aid in Fight Against Coronavirus?.NEWS3: Pfizer Stock Rises 3%.
2020-04-15: NEWS1: Mylan's Robert Coury back as executive chairman.NEWS2: Mylan names Coury executive chairman again.NEWS3: Pfizer (PFE) Stock Moves -1.26%: What You Should Know.NEWS4: TBJ Plus: Industries with the most PPP loans; Raleigh's Meeker sounds off; Retail sees biggest drop on record.NEWS5: The Zacks Analyst Blog Highlights: Pluristem Therapeutics, Mesoblast, Gilead Sciences, Pfizer and Regeneron.NEWS6: Pharma Stocks Rally on Sanofi, GSK Coronavirus Vaccine Tie-Up.

Answer: Decrease